Key statistics
On Monday, Theravance Biopharma Inc (0TB:FRA) closed at 8.95, -15.57% below its 52-week high of 10.60, set on Jan 04, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 8.95 |
---|---|
High | 8.95 |
Low | 8.95 |
Bid | 9.00 |
Offer | 9.10 |
Previous close | 9.10 |
Average volume | 312.57 |
---|---|
Shares outstanding | 48.92m |
Free float | 46.01m |
P/E (TTM) | -- |
Market cap | 463.29m USD |
EPS (TTM) | -1.01 USD |
Data delayed at least 15 minutes, as of Nov 25 2024 07:16 GMT.
More ▼
Press releases
- Theravance Biopharma to Participate in an Upcoming Investor Conference
- Theravance Biopharma, Inc. Reports Third Quarter 2024 Financial Results and Announces Initiatives to Unlock Shareholder Value
- Theravance Biopharma to Report Third Quarter 2024 Financial Results on November 12, 2024
- Theravance Announces Publication of YUPELRI® (revefenacin) Area Under the Curve Spirometry Analysis in the International Journal of Chronic Obstructive Pulmonary Disease